Evidence-Based Complementary and Alternative Medicine

Traditional Chinese Medicine in Ischemia-Reperfusion Injury


Publishing date
01 Oct 2021
Status
Published
Submission deadline
04 Jun 2021

Lead Editor

1Southern University of Science and Technology, Shenzhen, China

2University of Southern California, Los Angeles, USA

3Emory University School of Medicine, Atlanta, USA


Traditional Chinese Medicine in Ischemia-Reperfusion Injury

Description

Clinically, reperfusion in ischemic tissue usually leads to morbidity and mortality in a wide range of pathological and surgical processes, including myocardial infarction, ischemic stroke, acute kidney injury, trauma, organ transplantation, and cardiothoracic, vascular, and general surgery.

Mechanistically, ischemia-reperfusion injury is associated with an enhanced production of inflammatory mediators, emigration of leukocytes in postcapillary venules, vascular protein leakage, activation of innate and adaptive immune responses, and cell death programs. Unfortunately, current medical strategies do not thoroughly diagnose and prevent this disease. Traditional Chinese medicine (TCM) contains numerous bioactive ingredients, some of which show activity against inflammatory mediators, inappropriate immune responses, and cell death.

This Special Issue invites research clinicians and scientists to submit original articles as well as reviews providing a comprehensive overview and high-quality research of TCM in ischemia-reperfusion injury. The work can evaluate the efficacy and safety of TCM for any kind of ischemia-reperfusion injury. We are particularly interested in manuscripts that report the physiological effects as well as the underlying mechanisms of TCM for ischemia-reperfusion injury.

Potential topics include but are not limited to the following:

  • Systematic review and/or meta-analysis of the use of TCM for ischemia-reperfusion injury
  • Biological and pharmacological activity of TCM for ischemia-reperfusion injury prevention and therapy
  • In vitro and in vivo study and toxicity evaluation of TCM for ischemia-reperfusion injury prevention and therapy
  • Active component screening of traditional medicine in ischemia-reperfusion injury prevention and therapy
  • Characterization of active ingredients in herbal plants that have prevention and therapy properties for ischemia-reperfusion injury
  • Quality control of effective Chinese herbs for ischemia-reperfusion injury prevention and therapy
  • Clinical trials on TCM for pain management ischemia-reperfusion injury prevention and therapy
  • Integrative applications of traditional medicine and modern medicine in ischemia-reperfusion injury prevention and therapy
  • Omics of traditional medicine in ischemia-reperfusion injury prevention and therapy
  • Challenges in the use of traditional medicine in ischemia-reperfusion injury prevention and therapy

Articles

  • Special Issue
  • - Volume 2021
  • - Article ID 4548367
  • - Research Article

Research Trends, Hot Spots, and Prospects for Traditional Chinese Medicine in the Field of Ischemia-Reperfusion Injury

Yu Sun | Yuan Cai | ... | Yan-mei Peng
  • Special Issue
  • - Volume 2021
  • - Article ID 4954070
  • - Review Article

Ischemia-Reperfusion Injury in Peripheral Artery Disease and Traditional Chinese Medicine Treatment

Zenghui Liang | Wentao Zhang | ... | Yanrong Zhang
  • Special Issue
  • - Volume 2021
  • - Article ID 7178868
  • - Research Article

Protective Effect of Joa-Gui Em through the Improvement of the NLRP3 and TLR4/NF-κb Signaling by Ischemia/Reperfusion-Induced Acute Renal Failure Rats

Se Won Na | Youn Jae Jang | ... | Dae Gill Kang
  • Special Issue
  • - Volume 2021
  • - Article ID 5584809
  • - Research Article

Pharmacological Mechanisms Underlying the Therapeutic Effects of Danhong Injection on Cerebral Ischemia

Yifei Qi | Yihuai Zou | ... | Zhong Wang
  • Special Issue
  • - Volume 2021
  • - Article ID 5564401
  • - Review Article

The Protective Effect of Traditional Chinese Medicine on Liver Ischemia-Reperfusion Injury

Wen Ma | Songling Tang | ... | Lu Gan
  • Special Issue
  • - Volume 2021
  • - Article ID 5556603
  • - Research Article

Resveratrol Alleviates Vascular Endothelial Damage Caused by Lower-Extremity Ischemia Reperfusion (I/R) through Regulating Keap1/Nrf2 Signaling-Mediated Oxidative Stress

Xiaojun Song | Zhili Liu | ... | Wei Ye
  • Special Issue
  • - Volume 2021
  • - Article ID 5597567
  • - Research Article

MiR-203 Targets to the 3′-UTR of SLUG to Suppress Cerebral Infarction-Induced Endothelial Cell Growth and Motility

Yunsong Li | Wei Bi | ... | Xiang Gao
  • Special Issue
  • - Volume 2021
  • - Article ID 5579327
  • - Review Article

Renal-Protective Effects and Potential Mechanisms of Traditional Chinese Medicine after Ischemia-Reperfusion Injury

Demin Liu | Songling Tang | ... | Wei Cui
  • Special Issue
  • - Volume 2021
  • - Article ID 6629718
  • - Research Article

Protective Role of Sulodexide on Renal Injury Induced by Limb Ischemia-Reperfusion

Tao Yuan | Ni Yang | ... | Xiang Gao
  • Special Issue
  • - Volume 2021
  • - Article ID 6654457
  • - Research Article

Protective Effects of Shenfuyixin Granule on H2O2-Induced Apoptosis in Neonatal Rat Cardiomyocytes

Xinlu Wang | Xuanxuan Hao | ... | Mingjun Zhu
Evidence-Based Complementary and Alternative Medicine
 Journal metrics
See full report
Acceptance rate7%
Submission to final decision145 days
Acceptance to publication29 days
CiteScore3.500
Journal Citation Indicator-
Impact Factor-

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.